What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Breast cancer, Cancer, Internal medicine, Oncology and Genetics. The concepts of his Breast cancer study are interwoven with issues in Genome-wide association study, Genotype, Single-nucleotide polymorphism and Ovarian cancer. The Genotype study combines topics in areas such as Allele and Immunology.
Frans B. L. Hogervorst has included themes like Genetic predisposition and Bioinformatics in his Single-nucleotide polymorphism study. He has researched Cancer in several fields, including Cancer research, Gynecology and Endocrinology. His Oncology study integrates concerns from other disciplines, such as Colorectal cancer, Endometrial cancer and MSH6.
His most cited work include:
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results (584 citations)
- MicroRNA related polymorphisms and breast cancer risk (582 citations)
- Laminin receptor on platelets is the integrin VLA-6. (582 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Breast cancer, Genetics, Internal medicine, Oncology and Cancer. His Breast cancer research incorporates elements of Cancer research and Single-nucleotide polymorphism, Genome-wide association study, Genotype. His research integrates issues of Haplotype, Gene mutation and Bioinformatics in his study of Single-nucleotide polymorphism.
Frans B. L. Hogervorst combines subjects such as Penetrance and Immunology with his study of Genotype. His Internal medicine research focuses on Pathology and how it relates to Comparative genomic hybridization. His work in Oncology covers topics such as Ovarian cancer which are related to areas like BRCA2 Protein.
He most often published in these fields:
- Breast cancer (61.33%)
- Genetics (38.00%)
- Internal medicine (32.67%)
What were the highlights of his more recent work (between 2015-2021)?
- Breast cancer (61.33%)
- Internal medicine (32.67%)
- Oncology (30.00%)
In recent papers he was focusing on the following fields of study:
His main research concerns Breast cancer, Internal medicine, Oncology, Genetics and Ovarian cancer. His biological study spans a wide range of topics, including CHEK2 and Single-nucleotide polymorphism, Genotype. His Oncology research includes themes of Germline mutation, Li–Fraumeni syndrome, Genetic predisposition, Case-control study and Gynecology.
His Germline mutation study combines topics in areas such as Genotyping and Genetic testing. His work on Locus, Allele, Genome-wide association study and Mutation as part of general Genetics research is frequently linked to Olaparib, thereby connecting diverse disciplines of science. His Ovarian cancer research includes elements of Complementation, Prostate, Proportional hazards model and Clinical significance.
Between 2015 and 2021, his most popular works were:
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (155 citations)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. (149 citations)
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (100 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Breast cancer, Oncology, Internal medicine, Genetics and Genotype. His research in Breast cancer intersects with topics in Case-control study and Cisplatin. His Oncology research integrates issues from Odds ratio, Pancreatic cancer, Estrogen receptor and Genetic predisposition.
The Genotype study combines topics in areas such as Ovarian cancer and Bioinformatics. His research on Genotyping also deals with topics like
- Germline mutation, Genetic testing and Gene mutation most often made with reference to Mutation rate,
- Allele and related Cancer research. His Germline mutation research is multidisciplinary, relying on both Cancer and Missense mutation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
